作者: Terry Chow , Chiaoli Yeh , David Griller , Leonard Yuen
DOI:
关键词:
摘要: The present invention relates to the treatment of cancer with compounds that inhibit activity endo-exonuclease. Endo-exonuclease has been shown be necessary for repair damaged DNA. Compounds endo-exonuclease have particularly effective treating when used in combination drugs induce DNA breaks such as cisplatin and mitomycin C. These a synergistic effect inhibiting tumour growth. includes pharmaceutical compositions growth comprising compound inhibits activity. preferably include breaks. methods these uses treat cancer. preferred low toxicity. One is pentamidine. also method diagnosing monitoring its progression. This aspect involves isolating serum from patient; measuring concentration said determining whether above predetermined mean.